GCH1 p.Ser80Asn variant associated with increased Parkinson's Disease risk in East Asian populationsRare GCH1 Variant Raises Parkinson's Risk in East Asians

medRxiv Published June 24, 2026 Study authors: Tay, Y. W.; Lee, A. L.; Schee, J. P.; Lin, C. H.; Tan, E. K.; Shin, J. H.; Chen, P.-S.; Fan, S.-P.; … DOI ↗ Editorial oversight: Dr. Julia Lee, PhD · Oncology, Genomics & Drug Development

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway

Recognize the GCH1 p.Ser80Asn variant as a rare, East Asian-enriched risk factor for Parkinson's Disease.

The study investigated the prevalence and clinical implications of the GCH1 p.Ser80Asn variant in East Asian populations diagnosed with Parkinson's Disease. By comparing carriers of this variant against non-carriers, researchers sought to determine if the genetic marker was associated with increased risk for the neurodegenerative condition.

The analysis found that the GCH1 p.Ser80Asn variant is enriched within these specific cohorts and is associated with an increased risk of Parkinson's Disease. The results suggest a significant association between this rare variant and the disease phenotype in East Asian populations, while also noting the age at onset for affected carriers.

While the findings highlight a specific genetic risk factor, it is important to note that these results indicate a statistical association rather than direct causation of the disease. Clinical application should be tempered by the fact that this is a rare variant and its role in individual clinical progression remains to be fully elucidated.

A large meta-analysis of East Asian populations has identified a rare genetic variant that significantly raises the risk of developing Parkinson's disease. The study, which combined data from the Global Parkinson's Genetics Program (GP2) and East Asian cohorts, included over 27,000 Parkinson's patients and 47,000 controls.

Researchers found that the GCH1 p.Ser80Asn variant was present in about 0.33% of Parkinson's patients in the GP2 East Asian group. Carriers of this variant had about a five times higher chance of developing Parkinson's compared to non-carriers. The average age at which symptoms began for carriers was around 56 years.

This variant is rare in the general population but appears to be enriched in East Asian populations. The findings suggest that genetic testing for this variant could help identify individuals at higher risk, though it does not mean that everyone with the variant will develop the disease.

The study highlights the importance of including diverse populations in genetic research. While the link is strong, more research is needed to understand how this variant contributes to Parkinson's and whether it could lead to new treatments.

What this means for you:

A rare GCH1 variant increases Parkinson's risk fivefold in East Asians, affecting about 1 in 300 patients.

Common questions

What is the GCH1 p.Ser80Asn variant?

The GCH1 p.Ser80Asn variant is a specific genetic marker that researchers identified as being more common in people with Parkinson's disease. In the study, it was found to be enriched in East Asian populations. While it is linked to an increased risk of the condition, it is considered a rare variant.

How much does this variant increase Parkinson's risk?

The study reported an odds ratio of 5.1 for individuals in East Asian populations who carried the GCH1 p.Ser80Asn variant. This means there is a measurable link between having this specific genetic marker and the likelihood of developing Parkinson's disease.

At what age do symptoms typically appear for those with this variant?

For individuals who carried the GCH1 p.Ser80Asn variant, the mean age at the onset of symptoms was approximately 56.3 years. This helps researchers understand the typical timeline for the disease in people with this specific genetic marker.

Study Details

Study typeMeta analysis

Sample sizen = 22,372

EvidenceLevel 1

PublishedJun 2026

View Original Abstract ↓

Introduction: GCH1 has been implicated in Parkinson's disease (PD), but its risks variants and associations are not well defined. Objectives: To investigate the clinical relevance and PD risk associated with the GCH1 p.Ser80Asn variant. Methods: We first identified a segregating GCH1 p.Ser80Asn variant in a Malaysian Chinese PD family via whole genome sequencing (WGS). We assessed its risk association using multi-ancestry WGS data from the Global Parkinson's Genetics Program (GP2) (n=22,372PD vs n=8,826Controls) and meta-analysis of East Asian (EAS) cohorts (n=4,712PD vs 38,733Controls). Clinico-demographic details of affected variant carriers were collated. Results: The GCH1 p.Ser80Asn variant was enriched in GP2 EAS PD populations (n=9/2,757; 0.33%) but not detected in other ancestries. Meta-analysis revealed increased PD risk in EAS populations (odds ratio:5.1; 95%CI:2.3-10.7; p=2.89x10-5). Affected carriers (mean age at onset:56.3+-12.5 years) had additional occurrence of dystonia, while dementia was rare. Conclusions: The GCH1 p.Ser80Asn variant is a rare, EAS-enriched risk variant for PD.

GCH1 p.Ser80Asn variant associated with increased Parkinson's Disease risk in East Asian populationsRare GCH1 Variant Raises Parkinson's Risk in East Asians

Common questions

Study Details

Genotype-Guided SSRI Prescribing Shows No Short-Term Benefit but Higher Remission at 6 Months

Genetic Testing Helps Some Depression Patients Feel Better Long Term

Clinical research that matters. Delivered to your inbox.

GCH1 p.Ser80Asn variant associated with increased Parkinson's Disease risk in East Asian populationsRare GCH1 Variant Raises Parkinson's Risk in East Asians

Common questions

More on Parkinson's Disease

Study Details

Genotype-Guided SSRI Prescribing Shows No Short-Term Benefit but Higher Remission at 6 Months

Genetic Testing Helps Some Depression Patients Feel Better Long Term

Clinical research that matters. Delivered to your inbox.

Related in Genetics & Precision Medicine

From Other Specialties